Background: African tick-bite fever occurs after contact with ticks that ca
rry Rickettsia africae and that parasitize cattle and game. Sporadic report
s suggest that this infection has specific clinical and epidemiologic featu
res.
Methods: We studied patients who were tested for a rickettsial disease afte
r returning from a visit to Africa or Guadeloupe. To assess the value of th
e microimmunofluorescence assay, Western blotting, and cross-adsorption ass
ays, we compared the results of these tests in 39 patients in whom African
tick-bite fever had been confirmed by the polymerase-chain-reaction assay,
cell culture, or both; 50 patients with documented R. conorii infection; an
d 50 blood donors. These diagnostic criteria were then applied to 376 addit
ional patients who had returned from southern Africa and 2 who had returned
from Guadeloupe and whose serum was being tested for rickettsial disease.
Results: In the 39 patients with direct evidence of R. africae infection, t
he combination of microimmunofluorescence assay, Western blotting, and cros
s-adsorption assays showing antibodies specific for R. africae had a sensit
ivity of 0.56; however, each test had a positive predictive value and a spe
cificity of 1.0. An additional 80 patients were found to have an R. africae
infection on the basis of these serologic criteria. Infections with R. afr
icae were acquired by visitors to 11 African countries and Guadeloupe. The
illness was generally mild and was characterized by a rash in 46 percent of
the patients; the rash was usually maculopapular or vesicular and rarely p
urpuric. Ninety-five percent of patients had an inoculation eschar or escha
rs, and 54 percent of these patients had multiple eschars, a finding that i
s unusual in patients with rickettsial infection.
Conclusions: In this series, R. africae was the cause of nearly all cases o
f tick-bite rickettsiosis in patients who became ill after a trip to sub-Sa
haran Africa. (N Engl J Med 2001;344:1504-10.) Copyright (C) 2001 Massachus
etts Medical Society.